| How to build and interpret a nomogram for cancer prognosis A Iasonos, D Schrag, GV Raj, KS Panageas Journal of clinical oncology 26 (8), 1364-1370, 2008 | 2511 | 2008 |
| Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: results of a questionnaire-based study E Basch, A Iasonos, T McDonough, A Barz, A Culkin, MG Kris, HI Scher, ... The lancet oncology 7 (11), 903-909, 2006 | 642 | 2006 |
| Adverse symptom event reporting by patients vs clinicians: relationships with clinical outcomes E Basch, X Jia, G Heller, A Barz, L Sit, M Fruscione, M Appawu, A Iasonos, ... JNCI: Journal of the National Cancer Institute 101 (23), 1624-1632, 2009 | 638 | 2009 |
| The incidence of symptomatic lower-extremity lymphedema following treatment of uterine corpus malignancies: a 12-year experience at Memorial Sloan-Kettering Cancer Center NR Abu-Rustum, K Alektiar, A Iasonos, G Lev, Y Sonoda, C Aghajanian, ... Gynecologic oncology 103 (2), 714-718, 2006 | 460 | 2006 |
| Risk-adapted dose-dense immunochemotherapy determined by interim FDG-PET in advanced-stage diffuse large B-cell lymphoma CH Moskowitz, H Schöder, J Teruya-Feldstein, C Sima, A Iasonos, ... Journal of clinical oncology 28 (11), 1896, 2010 | 388 | 2010 |
| Efficacy of MEK inhibition in patients with histiocytic neoplasms EL Diamond, BH Durham, GA Ulaner, E Drill, J Buthorn, M Ki, L Bitner, ... Nature 567 (7749), 521-524, 2019 | 259 | 2019 |
| A multicenter prospective trial evaluating the ability of preoperative computed tomography scan and serum CA-125 to predict suboptimal cytoreduction at primary debulking … RS Suidan, PT Ramirez, DM Sarasohn, JB Teitcher, S Mironov, RB Iyer, ... Gynecologic oncology 134 (3), 455-461, 2014 | 259 | 2014 |
| Squamous cell carcinoma arising in mature cystic teratoma of the ovary: a case series and review of the literature L Dos Santos, E Mok, A Iasonos, K Park, RA Soslow, C Aghajanian, ... Gynecologic oncology 105 (2), 321-324, 2007 | 237 | 2007 |
| Long-term toxicity monitoring via electronic patient-reported outcomes in patients receiving chemotherapy E Basch, A Iasonos, A Barz, A Culkin, MG Kris, D Artz, P Fearn, ... Journal of Clinical Oncology 25 (34), 5374-5380, 2007 | 225 | 2007 |
| BRAF mutation is associated with early stage disease and improved outcome in patients with low‐grade serous ovarian cancer RN Grisham, G Iyer, K Garg, D DeLair, DM Hyman, Q Zhou, A Iasonos, ... Cancer 119 (3), 548-554, 2013 | 218 | 2013 |
| A comprehensive comparison of the continual reassessment method to the standard 3+ 3 dose escalation scheme in Phase I dose-finding studies A Iasonos, AS Wilton, ER Riedel, VE Seshan, DR Spriggs Clinical Trials 5 (5), 465-477, 2008 | 192 | 2008 |
| A nomogram to predict postresection 5‐year overall survival for patients with uterine leiomyosarcoma O Zivanovic, LM Jacks, A Iasonos, MM Leitao Jr, RA Soslow, E Veras, ... Cancer 118 (3), 660-669, 2012 | 166 | 2012 |
| Renal cell carcinoma in young and old patients—is there a difference? RH Thompson, MA Ordonez, A Iasonos, FP Secin, B Guillonneau, ... The Journal of urology 180 (4), 1262-1266, 2008 | 162 | 2008 |
| Pilot study of a heptavalent vaccine-keyhole limpet hemocyanin conjugate plus QS21 in patients with epithelial ovarian, fallopian tube, or peritoneal cancer PJ Sabbatini, G Ragupathi, C Hood, CA Aghajanian, M Juretzka, ... Clinical cancer research 13 (14), 4170-4177, 2007 | 162 | 2007 |
| Is there a therapeutic impact to regional lymphadenectomy in the surgical treatment of endometrial carcinoma? NR Abu-Rustum, A Iasonos, Q Zhou, E Oke, RA Soslow, KM Alektiar, ... American journal of obstetrics and gynecology 198 (4), 457. e1-457. e6, 2008 | 154 | 2008 |
| Stage-specific outcomes of patients with uterine leiomyosarcoma: a comparison of the international Federation of gynecology and obstetrics and american joint committee on … O Zivanovic, MM Leitao, A Iasonos, LM Jacks, Q Zhou, NR Abu-Rustum, ... Journal of Clinical Oncology 27 (12), 2066, 2009 | 152 | 2009 |
| A 2-year prospective study assessing the emotional, sexual, and quality of life concerns of women undergoing radical trachelectomy versus radical hysterectomy for treatment of … J Carter, Y Sonoda, RE Baser, L Raviv, DS Chi, RR Barakat, A Iasonos, ... Gynecologic oncology 119 (2), 358-365, 2010 | 147 | 2010 |
| The impact of bulky upper abdominal disease cephalad to the greater omentum on surgical outcome for stage IIIC epithelial ovarian, fallopian tube, and primary peritoneal cancer O Zivanovic, EL Eisenhauer, Q Zhou, A Iasonos, P Sabbatini, Y Sonoda, ... Gynecologic oncology 108 (2), 287-292, 2008 | 144 | 2008 |
| Phase II trial of pemetrexed as second-line therapy in patients with metastatic urothelial carcinoma MD Galsky, S Mironov, A Iasonos, J Scattergood, MG Boyle, DF Bajorin Investigational new drugs 25, 265-270, 2007 | 141 | 2007 |
| Evaluation of an online platform for cancer patient self-reporting of chemotherapy toxicities E Basch, D Artz, A Iasonos, J Speakman, K Shannon, K Lin, C Pun, ... Journal of the American Medical Informatics Association 14 (3), 264-268, 2007 | 140 | 2007 |
